CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change
- 4 Shares withheld for taxes Director gave up 4,731 shares (to pay taxes)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Planned sale Director sold 16,363 shares at $22.85 ($373,895)
- 4 Planned sale Director sold 20,000 shares at $22.15 ($443,000)
- 4 Open-market sale Director sold 20,000 shares at an average $22.49 ($449,817)
- 4 Open-market sale Principal Accounting Officer sold 504 shares at $24.29 ($12,242)
- 8-K Event Bylaws or fiscal year change
- 4 Shares withheld for taxes Principal Accounting Officer gave up 273 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Legal Officer gave up 1,129 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Medical Officer gave up 1,134 shares (to pay taxes)
- 4 Open-market sale Director sold 20,000 shares at $25.37 ($507,400)
- S-8 Other Securities Offered to Employees in Benefit Plans
Page 17 of 66 · 1,304 filings